Phonak Audéo Lumity vs Resound Vivia 9 60S microRIE

The Phonak Audéo Lumity is a premium prescription behind-the-ear hearing aid released in 2022, priced at $4,398. In HearAdvisor's independent lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #23 among 39 prescription hearing aids tested. This device demonstrates particular strength in music streaming, scoring 4.1/5—a strong result that sits 1.34 points above the category average. Feedback handling is excellent at 5.0/5, providing reliable stability during wear. Speech clarity in quiet environments is solid at 3.7/5, measuring 0.29 points above average for prescription aids. However, the Lumity shows notable limitations. Own-voice comfort scores just 1.0/5, falling 1.70 points below the category average—a significant weakness that may affect user satisfaction during conversations. Speech understanding in noisy environments, while technically above average by 0.04 points, remains mixed in absolute terms at 2.1/5. The Audéo Lumity includes rechargeable batteries, streaming compatibility with both iPhone and Android devices, and hands-free calling capability. It received HearAdvisor's Expert's Choice Award in both 2023 and 2024. This hearing aid may suit users who prioritize music enjoyment and streaming quality, though those sensitive to own-voice perception or frequently in noisy environments may want to explore alternatives in this price tier.

The ReSound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In our lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #29 of 39 prescription hearing aids tested. This device shows a mixed performance profile. Its standout strength is own-voice comfort, scoring 3.4/5—a solid result that sits 0.70 points above the category average. Speech clarity in quiet environments also performs at category average with a score of 3.4/5. Feedback handling is strong in absolute terms at 4.2/5, though this falls 0.52 points below the category average, reflecting the high bar set by competing prescription devices. The Vivia 9's most notable weakness is speech understanding in noisy environments, where it scored just 1.1/5—a low result that trails the category average by 0.96 points. Music streaming performance is mixed at 2.6/5, sitting slightly below average. These limitations are worth considering given the premium price positioning. For listeners who prioritize comfortable own-voice perception and primarily encounter quieter listening situations, the Vivia 9 may be suitable. However, those frequently in challenging noise environments should note that several alternatives in this price range—including the Phonak Sphere Infinio and Oticon Intent—deliver stronger overall performance in our testing. Budget-conscious shoppers may also find comparable sound quality at lower price points with options like the Jabra Enhance Pro 20 at Costco.